About Dispendix
Dispendix is a company based in Stuttgart (Germany) founded in 2015 was acquired by CELLINK in November 2018. The company has 23 employees. Dispendix operates in a competitive market with competitors including Opentrons, LabCyte, Tecan, Andrew Alliance and Scienion, among others.
- Headquarter Stuttgart, Germany
- Employees 23
- SectorsHealthcare
- Email••••••••
- Website dispendix.com
- Acquired by CELLINK (Nov 2018)
- Legal Name Dispendix Gmbh
Investors in Dispendix
Dispendix has secured backing from 1 investor. Prominent investors backing the company include CELLINK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
3D bioprinters and bioinks are developed for research applications. | 2016 | cellink.com | Boston, United States |
Investor details for Dispendix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Dispendix
6 people are tracked at Dispendix (3 in leadership, 3 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Nela Milićević Bošnjak | Head Of Quality Control & Testing | Leadership |
Christian Sesterheim | Head Of Operations | Leadership |
Edmund Yap | Managing Director, Director Of Sales, Applications & Support Biosciences Asia Pacific | Leadership |
Adriana Lopez Cruz | Supply Chain Coordinator | Team |
Dr. Felicia Truckenmueller | Manager Field Applications BU Lab Instruments | Team |
Bob Freese | Team Lead, US Field Application Specialist L2 & Field Service Engineer L2 | Team |
Complete people profiles for Dispendix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Dispendix
2 dated milestones of Dispendix across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Dispendix is founded.
- Exit Acquired by CELLINK.
Competitors of Dispendix
Dispendix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, LabCyte, Tecan, Andrew Alliance and Scienion, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opentrons.com | 2013 | Brooklyn, United States | $240.56M | 177 | Pipetting robots for laboratory automation are developed. | |
| labcyte.com | 2000 | Sunnyvale, United States | $33.39M | 184 | Acoustic liquid handling is developed for life science research. | |
| tecan.com | 1980 | Mannedorf, Switzerland | – | – | Automated laboratory instruments, robotics, and diagnostic solutions are provided. | |
| andrewalliance.com | 2011 | Vernier, Switzerland | $14.03M | 5 | Provider of automated liquid handling tools and software for scientific labs | |
| scienion.com | 2000 | Berlin, Germany | $5.67M | 114 | Non-contact dispensing solutions for genomics and proteomics are provided. | |
| flow-robotics.com | 2015 | Copenhagen, Denmark | $17.15M | 16 | AI-based robots for laboratory liquid handling automation are provided. | |
| ginolis.com | 2010 | Oulunsalo, Finland | $2.41M | – | Liquid handling and lab automation robots | |
| seedbiosciences.com | 2018 | Renens, Switzerland | $1.53M | – | Programmable robotic liquid handling systems for cell isolation are developed. | |
| avidien.com | 2009 | Hudson, United States | $4M | – | Automated liquid handling systems are developed for research labs. | |
| alphasip.es | 2008 | Zaragoza, Spain | – | – | Nanotube-based biosensor chips are produced for real-time medical diagnostics. |
Detailed competitors of Dispendix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Dispendix
The website of Dispendix (dispendix.com) receives about 34.1K visits a month.
- Monthly visits34.1K
▼ 19.8% vs previous month
Websites whose visitors overlap most with Dispendix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| opentrons.com | 100% | 51.5K | #542,302 | View details | |
| integra-biosciences.com | 99% | – | #432,153 | View details | |
| corning.com | 96% | 606.5K | #95,499 | View details | |
| tecan.com | 80% | 86.6K | #416,898 | View details | |
| americanlaboratorytrading.com | 60% | 58.8K | #558,835 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Dispendix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Dispendix
10 companies that operate in the same segment as Dispendix (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dispendix
Dispendix was founded in 2015.
Dispendix is headquartered in Stuttgart, Germany. It is registered at Stuttgart, Baden-wurttemberg, Germany.
Dispendix has 23 employees.
Dispendix offers a new generation of simple and reliable non-contact nanoliter dispensing products. The Immediate Drop on Demand Technology, I-DOT, enables dispensing of a large variety of liquids, including but not limited to aqueos solutions, PCR-buffer, DMSO up to 100 as well as living cells. I-DOT is scalable from single samples to high throughput. The general principle is simply based on a hole in the bottom of a microtiter plate well. Capillary forces keep the sample liquid in the cavity. By applying a well-defined pressure pulse on top of the well a droplet is formed and a high precise and accurate nanoliter droplet is released into or onto nearly any destination. Larger volumes are achieved by applying up to 400 pulses per second. Applications include PCR preparation, IC50 Studies, Cell Printing, Array Generation.
Dispendix's top competitors include Opentrons, Tecan and Andrew Alliance.
Dispendix has 1 investor. Key investors include CELLINK.
Dispendix operates through Dispendix Gmbh.
Yes. Dispendix was acquired by CELLINK in November 2018.